Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings

Jen Jen Su, Manabu Osoegawa, Takeshi Matsuoka, Motozumi Minohara, Masahito Tanaka, Takaaki Ishizu, Futoshi Mihara, Takayuki Taniwaki, Jun Ichi Kira

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Vascular permeability changes precede the development of demyelinating lesions in multiple sclerosis (MS), and vessel wall thickening and capillary proliferation are frequently seen in autopsied MS lesions. Although vascular growth factors are critical for inducing such vascular changes, their involvement in MS has not been extensively studied. Thus, we examined the involvement of various vascular growth factors in MS according to their clinical phase and subtype. We measured serum levels of vascular endothelial growth factor (VEGF), acidic and basic fibroblast growth factors (FGF) and platelet-derived growth factors (PDGFs)-AA, -AB and -BB in 50 patients with MS (27 opticospinal MS and 23 conventional MS patients) and 33 healthy controls using sandwich enzyme immunoassays. Correlations between growth factor changes and brain and spinal cord MRI findings were then analyzed. Serum VEGF concentrations were significantly higher in MS patients in relapse than in controls (p = 0.0495) and in MS patients in remission (p = 0.0003), irrespective of clinical subtype. Basic FGF was significantly increased in conventional MS patients, but not opticospinal MS patients compared with controls (p = 0.0291), irrespective of clinical phase. VEGF at relapse showed a significant positive correlation with the length of spinal cord lesions on MRI (r = 0.506, p = 0.0319). The results suggest that an increase in serum VEGF concentration might be involved in MS relapse and the formation of longitudinally extensive spinal cord lesions.

Original languageEnglish
Pages (from-to)21-30
Number of pages10
JournalJournal of the Neurological Sciences
Volume243
Issue number1-2
DOIs
Publication statusPublished - Apr 15 2006

Fingerprint

Multiple Sclerosis
Intercellular Signaling Peptides and Proteins
Up-Regulation
Vascular Endothelial Growth Factor A
Spinal Cord
Fibroblast Growth Factor 2
Recurrence
Serum
vascular factor
Fibroblast Growth Factor 1
Capillary Permeability
Immunoenzyme Techniques
Blood Vessels
Brain

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Upregulation of vascular growth factors in multiple sclerosis : Correlation with MRI findings. / Su, Jen Jen; Osoegawa, Manabu; Matsuoka, Takeshi; Minohara, Motozumi; Tanaka, Masahito; Ishizu, Takaaki; Mihara, Futoshi; Taniwaki, Takayuki; Kira, Jun Ichi.

In: Journal of the Neurological Sciences, Vol. 243, No. 1-2, 15.04.2006, p. 21-30.

Research output: Contribution to journalArticle

Su, JJ, Osoegawa, M, Matsuoka, T, Minohara, M, Tanaka, M, Ishizu, T, Mihara, F, Taniwaki, T & Kira, JI 2006, 'Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings', Journal of the Neurological Sciences, vol. 243, no. 1-2, pp. 21-30. https://doi.org/10.1016/j.jns.2005.11.006
Su, Jen Jen ; Osoegawa, Manabu ; Matsuoka, Takeshi ; Minohara, Motozumi ; Tanaka, Masahito ; Ishizu, Takaaki ; Mihara, Futoshi ; Taniwaki, Takayuki ; Kira, Jun Ichi. / Upregulation of vascular growth factors in multiple sclerosis : Correlation with MRI findings. In: Journal of the Neurological Sciences. 2006 ; Vol. 243, No. 1-2. pp. 21-30.
@article{6c77d761b1cd497b9db3f58d4c57c883,
title = "Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings",
abstract = "Vascular permeability changes precede the development of demyelinating lesions in multiple sclerosis (MS), and vessel wall thickening and capillary proliferation are frequently seen in autopsied MS lesions. Although vascular growth factors are critical for inducing such vascular changes, their involvement in MS has not been extensively studied. Thus, we examined the involvement of various vascular growth factors in MS according to their clinical phase and subtype. We measured serum levels of vascular endothelial growth factor (VEGF), acidic and basic fibroblast growth factors (FGF) and platelet-derived growth factors (PDGFs)-AA, -AB and -BB in 50 patients with MS (27 opticospinal MS and 23 conventional MS patients) and 33 healthy controls using sandwich enzyme immunoassays. Correlations between growth factor changes and brain and spinal cord MRI findings were then analyzed. Serum VEGF concentrations were significantly higher in MS patients in relapse than in controls (p = 0.0495) and in MS patients in remission (p = 0.0003), irrespective of clinical subtype. Basic FGF was significantly increased in conventional MS patients, but not opticospinal MS patients compared with controls (p = 0.0291), irrespective of clinical phase. VEGF at relapse showed a significant positive correlation with the length of spinal cord lesions on MRI (r = 0.506, p = 0.0319). The results suggest that an increase in serum VEGF concentration might be involved in MS relapse and the formation of longitudinally extensive spinal cord lesions.",
author = "Su, {Jen Jen} and Manabu Osoegawa and Takeshi Matsuoka and Motozumi Minohara and Masahito Tanaka and Takaaki Ishizu and Futoshi Mihara and Takayuki Taniwaki and Kira, {Jun Ichi}",
year = "2006",
month = "4",
day = "15",
doi = "10.1016/j.jns.2005.11.006",
language = "English",
volume = "243",
pages = "21--30",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Upregulation of vascular growth factors in multiple sclerosis

T2 - Correlation with MRI findings

AU - Su, Jen Jen

AU - Osoegawa, Manabu

AU - Matsuoka, Takeshi

AU - Minohara, Motozumi

AU - Tanaka, Masahito

AU - Ishizu, Takaaki

AU - Mihara, Futoshi

AU - Taniwaki, Takayuki

AU - Kira, Jun Ichi

PY - 2006/4/15

Y1 - 2006/4/15

N2 - Vascular permeability changes precede the development of demyelinating lesions in multiple sclerosis (MS), and vessel wall thickening and capillary proliferation are frequently seen in autopsied MS lesions. Although vascular growth factors are critical for inducing such vascular changes, their involvement in MS has not been extensively studied. Thus, we examined the involvement of various vascular growth factors in MS according to their clinical phase and subtype. We measured serum levels of vascular endothelial growth factor (VEGF), acidic and basic fibroblast growth factors (FGF) and platelet-derived growth factors (PDGFs)-AA, -AB and -BB in 50 patients with MS (27 opticospinal MS and 23 conventional MS patients) and 33 healthy controls using sandwich enzyme immunoassays. Correlations between growth factor changes and brain and spinal cord MRI findings were then analyzed. Serum VEGF concentrations were significantly higher in MS patients in relapse than in controls (p = 0.0495) and in MS patients in remission (p = 0.0003), irrespective of clinical subtype. Basic FGF was significantly increased in conventional MS patients, but not opticospinal MS patients compared with controls (p = 0.0291), irrespective of clinical phase. VEGF at relapse showed a significant positive correlation with the length of spinal cord lesions on MRI (r = 0.506, p = 0.0319). The results suggest that an increase in serum VEGF concentration might be involved in MS relapse and the formation of longitudinally extensive spinal cord lesions.

AB - Vascular permeability changes precede the development of demyelinating lesions in multiple sclerosis (MS), and vessel wall thickening and capillary proliferation are frequently seen in autopsied MS lesions. Although vascular growth factors are critical for inducing such vascular changes, their involvement in MS has not been extensively studied. Thus, we examined the involvement of various vascular growth factors in MS according to their clinical phase and subtype. We measured serum levels of vascular endothelial growth factor (VEGF), acidic and basic fibroblast growth factors (FGF) and platelet-derived growth factors (PDGFs)-AA, -AB and -BB in 50 patients with MS (27 opticospinal MS and 23 conventional MS patients) and 33 healthy controls using sandwich enzyme immunoassays. Correlations between growth factor changes and brain and spinal cord MRI findings were then analyzed. Serum VEGF concentrations were significantly higher in MS patients in relapse than in controls (p = 0.0495) and in MS patients in remission (p = 0.0003), irrespective of clinical subtype. Basic FGF was significantly increased in conventional MS patients, but not opticospinal MS patients compared with controls (p = 0.0291), irrespective of clinical phase. VEGF at relapse showed a significant positive correlation with the length of spinal cord lesions on MRI (r = 0.506, p = 0.0319). The results suggest that an increase in serum VEGF concentration might be involved in MS relapse and the formation of longitudinally extensive spinal cord lesions.

UR - http://www.scopus.com/inward/record.url?scp=33645092394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645092394&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2005.11.006

DO - 10.1016/j.jns.2005.11.006

M3 - Article

C2 - 16376944

AN - SCOPUS:33645092394

VL - 243

SP - 21

EP - 30

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -